Labcorp Holdings (LH) Stock Forecast & Price Target

Compare

1,128 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LH Analyst Ratings

Strong Buy

6 Buy

2 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Labcorp

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LH Stock 12 Month Forecast

Average Price Target

$299.75

▲(10.12% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is $299.75 with a high forecast of $325.00 and a low forecast of $270.00. The average price target represents a 10.12% change from the last price of $272.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"225":"$225","326":"$326","250.25":"$250.3","275.5":"$275.5","300.75":"$300.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$325.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":299.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$299.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$270.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[225,250.25,275.5,300.75,326],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.88,256.58153846153846,262.2830769230769,267.9846153846154,273.68615384615384,279.3876923076923,285.08923076923077,290.79076923076923,296.4923076923077,302.19384615384615,307.8953846153846,313.5969230769231,319.29846153846154,{"y":325,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.88,254.63923076923078,258.39846153846156,262.1576923076923,265.91692307692307,269.67615384615385,273.43538461538463,277.19461538461536,280.95384615384614,284.7130769230769,288.4723076923077,292.23153846153843,295.9907692307692,{"y":299.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.88,252.35076923076923,253.82153846153847,255.2923076923077,256.76307692307694,258.2338461538462,259.7046153846154,261.1753846153846,262.6461538461538,264.11692307692306,265.5876923076923,267.05846153846153,268.52923076923076,{"y":270,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":237.989,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":226.803,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":247.059,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":248.996,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.756,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.316,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.551,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":262.875,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":260.129,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.315,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":253.282,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.88,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$325.00

Average Price Target$299.75

Lowest Price Target$270.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Eric Coldwell

Robert W. Baird

$307→$313

Buy

14.99%

Upside

Reiterated

01/14/26

Labcorp price target raised to $313 from $307 at BairdLabcorp price target raised to $313 from $307 at Baird

Elizabeth Anderson CFA

Evercore ISI

$280

Buy

2.87%

Upside

Reiterated

01/14/26

Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)

Patrick B Donnelly

Citi

$325

Buy

19.40%

Upside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Erin Wright

Morgan Stanley

$308

Buy

13.15%

Upside

Reiterated

12/18/25

Morgan Stanley Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Michael Ryskin

Bank of America Securities

$295

Buy

8.38%

Upside

Reiterated

12/15/25

Labcorp Holdings (LH) Receives a Buy from Bank of America Securities

Luke Sergott

Barclays

$290

Hold

6.54%

Upside

Reiterated

12/15/25

Barclays Reaffirms Their Hold Rating on Labcorp Holdings (LH)

David Westenberg

Piper Sandler

$280→$270

Hold

-0.81%

Downside

Reiterated

11/10/25

Labcorp price target lowered to $270 from $280 at Piper SandlerLabcorp price target lowered to $270 from $280 at Piper Sandler

Lisa Gill

J.P. Morgan

$291→$317

Buy

16.46%

Upside

Reiterated

11/07/25

Labcorp price target raised to $317 from $291 at JPMorganLabcorp price target raised to $317 from $291 at JPMorgan

David S Macdonald

Truist Financial

$320

Buy

17.56%

Upside

Reiterated

10/29/25

Truist Financial Sticks to Its Buy Rating for Labcorp Holdings (LH)

Kevin Caliendo

UBS

$325→$320

Buy

17.56%

Upside

Reiterated

10/29/25

Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS

Andrew Brackmann

William Blair

Buy

―

Reiterated

10/28/25

Labcorp Holdings: Strong Performance and Strategic Growth Drive Buy Rating

Ann Hynes

Mizuho Securities

$285→$320

Buy

17.56%

Upside

Reiterated

10/17/25

Labcorp price target raised to $320 from $285 at MizuhoLabcorp price target raised to $320 from $285 at Mizuho

Michael Cherny

Leerink Partners

$323→$342

Buy

25.64%

Upside

Reiterated

10/08/25

Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Tycho Peterson

Jefferies

$300

Buy

10.21%

Upside

Reiterated

07/25/25

Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating

Sidharth Sahoo

HSBC

$260

Hold

-4.48%

Downside

Downgraded

07/10/25

Labcorp downgraded to Hold from Buy at HSBCLabcorp downgraded to Hold from Buy at HSBC

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Eric Coldwell

Robert W. Baird

$307→$313

Buy

14.99%

Upside

Reiterated

01/14/26

Labcorp price target raised to $313 from $307 at BairdLabcorp price target raised to $313 from $307 at Baird

Elizabeth Anderson CFA

Evercore ISI

$280

Buy

2.87%

Upside

Reiterated

01/14/26

Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)

Patrick B Donnelly

Citi

$325

Buy

19.40%

Upside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Erin Wright

Morgan Stanley

$308

Buy

13.15%

Upside

Reiterated

12/18/25

Morgan Stanley Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Michael Ryskin

Bank of America Securities

$295

Buy

8.38%

Upside

Reiterated

12/15/25

Labcorp Holdings (LH) Receives a Buy from Bank of America Securities

Luke Sergott

Barclays

$290

Hold

6.54%

Upside

Reiterated

12/15/25

Barclays Reaffirms Their Hold Rating on Labcorp Holdings (LH)

David Westenberg

Piper Sandler

$280→$270

Hold

-0.81%

Downside

Reiterated

11/10/25

Labcorp price target lowered to $270 from $280 at Piper SandlerLabcorp price target lowered to $270 from $280 at Piper Sandler

Lisa Gill

J.P. Morgan

$291→$317

Buy

16.46%

Upside

Reiterated

11/07/25

Labcorp price target raised to $317 from $291 at JPMorganLabcorp price target raised to $317 from $291 at JPMorgan

David S Macdonald

Truist Financial

$320

Buy

17.56%

Upside

Reiterated

10/29/25

Truist Financial Sticks to Its Buy Rating for Labcorp Holdings (LH)

Kevin Caliendo

UBS

$325→$320

Buy

17.56%

Upside

Reiterated

10/29/25

Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS

Andrew Brackmann

William Blair

Buy

―

Reiterated

10/28/25

Labcorp Holdings: Strong Performance and Strategic Growth Drive Buy Rating

Ann Hynes

Mizuho Securities

$285→$320

Buy

17.56%

Upside

Reiterated

10/17/25

Labcorp price target raised to $320 from $285 at MizuhoLabcorp price target raised to $320 from $285 at Mizuho

Michael Cherny

Leerink Partners

$323→$342

Buy

25.64%

Upside

Reiterated

10/08/25

Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Tycho Peterson

Jefferies

$300

Buy

10.21%

Upside

Reiterated

07/25/25

Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating

Sidharth Sahoo

HSBC

$260

Hold

-4.48%

Downside

Downgraded

07/10/25

Labcorp downgraded to Hold from Buy at HSBCLabcorp downgraded to Hold from Buy at HSBC

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

LH Analyst Recommendation Trends

Rating

Aug 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LH has received 16 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. LH average Analyst price target in the past 3 months is 299.75.

Each month's total comprises the sum of three months' worth of ratings.

LH Financial Forecast

LH Earnings Forecast

Next quarter’s earnings estimate for LH is $3.94 with a range of $3.79 to $4.00. The previous quarter’s EPS was $4.18. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Sales Forecast

Next quarter’s sales forecast for LH is $3.56B with a range of $3.50B to $3.59B. The previous quarter’s sales results were $3.56B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Stock Forecast FAQ

What is LH’s average 12-month price target, according to analysts?

Based on analyst ratings, Labcorp Holdings’s 12-month average price target is 299.75.

What is LH’s upside potential, based on the analysts’ average price target?

Labcorp Holdings has 10.12% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LH a Buy, Sell or Hold?

Labcorp Holdings has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.

What is Labcorp Holdings’s price target?

The average price target for Labcorp Holdings is 299.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $325.00 ,the lowest forecast is $270.00. The average price target represents 10.12% Increase from the current price of $272.2.

What do analysts say about Labcorp Holdings?

Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of LH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Labcorp Holdings (LH) Stock Forecast & Price Target

LH Analyst Ratings

LH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

LH Analyst Recommendation Trends

LH Financial Forecast

LH Earnings Forecast

LH Sales Forecast

LH Stock Forecast FAQ

Detailed List of Analyst Forecasts